| Authors: |
Heflich RH; U.S. Food and Drug Administration, National Center for Toxicological Research, USA. Electronic address: robert.heflich@fda.hhs.gov., Bishop ME; U.S. Food and Drug Administration, National Center for Toxicological Research, USA., Mittelstaedt RA; U.S. Food and Drug Administration, National Center for Toxicological Research, USA., Yan J; U.S. Food and Drug Administration, National Center for Toxicological Research, USA., Guerrero SK; U.S. Food and Drug Administration, National Center for Toxicological Research, USA., Sims AM; U.S. Food and Drug Administration, National Center for Toxicological Research, USA., Mitchell K; U.S. Food and Drug Administration, National Center for Toxicological Research, USA., Moore N; U.S. Food and Drug Administration, National Center for Toxicological Research, USA., Li X; U.S. Food and Drug Administration, National Center for Toxicological Research, USA., Mei N; U.S. Food and Drug Administration, National Center for Toxicological Research, USA., Elespuru RK; U.S Food and Drug Administration, USA., King ST; U.S. Food and Drug Administration, Center for Drug Evaluation and Research, Office of Generic Drugs, USA., Keire DA; U.S. Food and Drug Administration, Center for Drug Evaluation and Research, Office of Pharmaceutical Quality, USA., Kruhlak NL; U.S. Food and Drug Administration, Center for Drug Evaluation and Research, Office of Translational Sciences, USA., Dorsam RT; U.S. Food and Drug Administration, Center for Drug Evaluation and Research, Office of Generic Drugs, USA., Raw AS; U.S. Food and Drug Administration, Center for Drug Evaluation and Research, Office of Pharmaceutical Quality, USA., Davis Bruno KL; U.S. Food and Drug Administration, Center for Drug Evaluation and Research, Office of New Drugs, USA., McGovern TJ; U.S. Food and Drug Administration, Center for Drug Evaluation and Research, Office of New Drugs, USA., Atrakchi AH; U.S. Food and Drug Administration, Center for Drug Evaluation and Research, Office of New Drugs, USA. |